← Back to Trial

Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer

Trial Locations

• University of California Davis Sacramento, California, United States
  • Contact: Mark Cokee · 916-734-8603 · [email protected] (opens in new tab)
• Dana-Farber Cancer Institute / Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Contact: Daniella Furtado · 617-525-8782 · [email protected] (opens in new tab)
• University of Michigan Health Ann Arbor, Michigan, United States
  • Contact: Main Line · 800-962-3555 · [email protected] (opens in new tab)
• U.T. MD Anderson Cancer Center Houston, Texas, United States
  • Contact: askMDAnderson · 877-632-6789 · [email protected] (opens in new tab)
• Fred Hutchinson Cancer Center Seattle, Washington, United States
  • Contact: Michael Schweizer, M.D. · 206-606-6252 · [email protected] (opens in new tab)
• Vancouver Prostate Centre Vancouver, British Columbia, Canada
  • Contact: Jonathan Ma · 16048755675 · [email protected] (opens in new tab)
• London Health Sciences Centre London, Ontario, Canada
  • Contact: Yoonbee Kim · 519-685-8500 Ext. 56916 · [email protected] (opens in new tab)
• Ottawa Hospital Research Institute (OHRI) Ottawa, Ontario, Canada
  • Contact: Pascale Juneau · 613-737-8899 Ext. 71064 · [email protected] (opens in new tab)
• University Health Network Toronto, Ontario, Canada
  • Contact: Jenny Su · 416-946-4501 Ext. 3141 · [email protected] (opens in new tab)